Valneva SE is a vaccine company focused on developing life-saving vaccines... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VALN is expected to report earnings to rise 183.36% to -38 cents per share on August 12
Q2'25
Est.
$-0.39
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.16
Q2'24
Missed
by $0.04
The last earnings report on May 07 showed earnings per share of -13 cents, beating the estimate of -20 cents. With 101.45K shares outstanding, the current market capitalization sits at 666.33M.